Skip to content

Prospective observational study of EGFR mutation allele frequency using Cell free DNA

Prospective observational study of EGFR mutation allele frequency using Cell free DNA - EGFR mutation allele frequency study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000036149
Enrollment
40
Registered
2019-03-13
Start date
2019-03-13
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

non small cell lung cancer

Interventions

None listed

Sponsors

Hamamatsu University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients with L858R mutation 2. Patients with unresectable or relapsing non small cell lung cancer 3. Patients over 20 years old at consent acquisition date 4. Patients receiving afatinib 5. Patients who can provide blood samples 6. Patients who agreed to participate in this study in writing

Exclusion criteria

Exclusion criteria: 1. Patients with interstitial pneumonia 2. Patients with serious complications 3. Patients with a history of serious hypersensitivity 4. Patients who are judged inappropriate to participate in this study by the research director or research contributor

Design outcomes

Primary

MeasureTime frame
Changes in EGFR mutation allele frequency

Countries

Japan

Contacts

Public ContactDaisuke Akahori

Hamamatsu University School of Medicine Second division, Depertment of Internal Medicine

dakahori@hama-med.ac.jp053-435-2263

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026